For more than 60 years, ELPEN Pharmaceuticals develops and manufactures for the Greek and international markets high quality, original and generic pharmaceutical products.

ELPEN is a privately family-owned, middle sized Greek pharmaceutical company with operations worldwide. Established in 1965, the group currently has more than 1100 employees and an annual turnover of €250 million.

Phone: +0030 211 1865 000. E-mail: [email protected]. Web: https://www.elpen.gr/ The production unit at Pikermi, Attica, is the beating heart of Elpen S.A. One unit is dedicated to the production of penicillin-containing oral solid formulations.

Για περισσότερο από 60 χρόνια, η φαρμακοβιομηχανία elpen αναπτύσσει και παράγει υψηλής ποιότητας πρωτότυπα και γενόσημα φάρμακα για την Ελληνική και τη διεθνή αγορά.

ELPEN is the leading Greek generics pharmaceutical company. With over 550 employees, presently the company ranks seventh amongst 400 companies, with an annual turnover of Euro130 million. We specialize in branded generics and originator products in CVS, CNS, respiratory, oncology, etc.

The Experimental, Educational & Research Center, ELPEN, in collaboration with ENAGO, actively supporting the scientific community, offers a series of free online training seminars to undergraduate, postgraduate and Ph.D. students as well as researchers of all levels of health sciences and other health professionals.

ELPEN drugs are exported to 60 countries worldwide, 27 of which are in Europe, with the primary aim to achieve further global expansion, spearheaded by Elpenhaler®, an original product, patented by the company's founder, Mr. Dimitrios Pentafragas.

ELPEN is the leading Greek generics pharmaceutical company. With over 550 employees, presently the company ranks seventh amongst 400 companies, with an annual turnover of Euro130 million. We specialize in branded generics and originator products in CVS, CNS, respiratory, oncology, etc.

ELPEN Pharmaceutical is a Distributor/Import Export company operating in the pharmaceutical industry. ELPEN is a privately family-owned, middle sized Greek pharmaceutical company with operations worldwide.

Aug 3, 2023 · EUR 55 million investment in a new factory in Keratea as part of a wider EUR 155 million spend up to 2025, ELPEN’s Theodore Tryfon outlines the company’s ambitious expansion and diversification plans; his hopes for the future of essential medicine manufacturing in Europe post-COVID; and what Greek pharma champions like ELPEN can offer the ...